Latest Monoamine oxidase Stories
A team of researchers from National University of Singapore (NUS) have created the first two-photon, small molecule fluorogenic probe that can serve as a useful tool for the rapid assessment of an individual's potential risk for Parkinson's disease.
What is it that makes a woman happy? Is it diamonds and furs, chocolate and wine, or a good book? No, apparently it's a gene.
Do you run when you should stay?
Heavy smokers may experience sadness after quitting because early withdrawal leads to an increase in the mood-related brain protein monoamine oxidase A (MAO-A), a new study by the Centre for Addiction and Mental Health (CAMH) has shown.
RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2011 /PRNewswire/ -- CeNeRx BioPharma, Inc., today reported that it has initiated a Phase II trial of its new formulation of TriRima(TM), the company's novel antidepressant in development as monotherapy for treatment resistant depression.
BURLINGTON, Mass., Nov.
RESEARCH TRIANGLE PARK, N.C., Nov.
RESEARCH TRIANGLE PARK, N.C., Aug. 13 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing.
Greater levels of a brain protein called monoamine oxidase A (MAO-A) â€“ may explain why postpartum blues and clinical depression are so common after childbirth.